samedan logo
 
 
spacer
home > pmps > autumn 2019 > the impact of emerging trends
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Impact of Emerging Trends





Quality assurance is critical in all industries, but in the pharmaceutical supply chain, the cost at stake is higher than most. As the industry shifts towards high-precision, low-volume therapies, pharma shipments become more sensitive, more expensive, and there are significant repercussions for temperature excursions or delayed deliveries. With the global pharma cold chain expected to reach $18 billion in spending by 2022, the impact of errors during transportation can result in compounded inefficiencies and increased costs throughout the entire supply chain, which ultimately affects the patients relying on these treatments.

Today, more rigorous transportation and storage requirements, such as advanced temperature control, sophisticated packaging, and additional monitoring and tracking requirements, are shaping the pharma distribution industry. The supply chain’s complexity is expanding; there is growing local and multi-jurisdictional regulatory oversight and increasing data requirements – all while precise delivery windows are shrinking. These shifting industry dynamics have led to significant changes in the way many pharma products are handled and highlight the industry’s need for high-quality specialty logistics solutions. Specifically, these solutions and their providers must address three critical drivers of change to maintain quality control: increasingly innovative therapies, expanding regulations, and the continued globalisation of the supply chain.
 

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Dr Ruediger Lomb is Vice President of Global Quality and Compliance for World Courier, as well as for Integrated Commercialisation Solutions, which are both AmerisourceBergen companies. In his role, Ruediger oversees the quality programme for both entities, ensuring facility and process compliance with all current and future GxP standards such as relevant FDA guidelines, the most recent EU GMP guidelines, and other relevant quality standards. He is a licensed pharmacist and holds a PhD in Pharmaceutical Biochemistry.


Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Show 2021 celebrates great success as it leads the way to build back business

The UK’s largest processing and packaging machinery event returned to the NEC, Birmingham (28-30 September) following the cancellation of the 2020 Show. Hailed as a great success by exhibitors and visitors, over 250 exhibitors and 1,250 brands showcased the latest innovations in smart manufacturing, processing equipment and packaging solutions.
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement